|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||6.40 - 6.40|
|52-week range||6.40 - 6.40|
|Beta (5Y monthly)||-0.42|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2021 - 13 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Homology Medicines (FIXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you love investing in stocks you're bound to buy some losers. But long term Homology Medicines, Inc. ( NASDAQ:FIXX...
Homology Medicines (FIXX) delivered earnings and revenue surprises of 96.92% and 3681.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?